Anzeige
Mehr »
Login
Mittwoch, 29.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Künstliche Intelligenz lässt die Nachfrage explodieren - so profitieren Anleger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CVW1 | ISIN: US23285D1090 | Ticker-Symbol: 8EQ
Frankfurt
29.05.24
08:59 Uhr
5,400 Euro
0,000
0,00 %
1-Jahres-Chart
CYTEK BIOSCIENCES INC Chart 1 Jahr
5-Tage-Chart
CYTEK BIOSCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,3505,50014:57
5,4005,50014:57

Aktuelle News zur CYTEK BIOSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCytek Biosciences, Inc.: 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek Biosciences Approved for Clinical Use in China69FREMONT, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China National Medical...
► Artikel lesen
20.05.Cytek Biosciences, Inc.: Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems2
13.05.Earnings call: Cytek Biosciences outlines robust Q1 growth, eyes expansion1
13.05.Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript1
09.05.Cytek Biosciences GAAP EPS of -$0.05, revenue of $44.9M1
08.05.Cytek Biosciences, Inc. - 10-Q, Quarterly Report1
08.05.Cytek Biosciences, Inc. - 8-K, Current Report1
08.05.Cytek Biosciences, Inc.: Cytek Biosciences Reports First Quarter 2024 Financial Results82FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results...
► Artikel lesen
30.04.Cytek Biosciences, Inc.: Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe1
29.04.Cytek Biosciences, Inc.: Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 20241
19.03.Cytek Biosciences CTO sells shares worth over $269k1
19.03.Cytek Biosciences, Inc. - 8-K, Current Report1
19.03.Cytek Biosciences Names William McCombe To Succeed Patrik Jeanmonod As CFO; Reaffirms 2024 Outlook-
19.03.Cytek appoints new CFO, reaffirms 2024 financial outlook1
19.03.Cytek Biosciences appoints CFO1
14.03.Cytek Biosciences, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
13.03.Cytek Biosciences, Inc. - 10-K, Annual Report 1
07.03.Cytek Biosciences, Inc.: Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions1
01.03.Cytek Biosciences, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4051
29.02.Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript1
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1